HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marlise R Luskin Selected Research

Polycythemia Vera

1/2022Transcriptional differences between JAK2-V617F and wild-type bone marrow cells in patients with myeloproliferative neoplasms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marlise R Luskin Research Topics

Disease

22Neoplasms (Cancer)
01/2024 - 09/2015
15Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2024 - 03/2016
10Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2024 - 08/2017
6Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 07/2015
5Leukemia
11/2023 - 12/2015
3Philadelphia Chromosome
11/2023 - 04/2022
3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
11/2023 - 06/2023
3Lymphoma (Lymphomas)
11/2023 - 04/2014
3Viremia
04/2008 - 12/2006
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2023 - 02/2020
2COVID-19
06/2023 - 01/2023
2Osteonecrosis (Kienbock's Disease)
11/2022 - 01/2022
1Fever (Fevers)
03/2024
1Hepatitis B
08/2023
1Fatigue
06/2023
1Capillary Leak Syndrome
03/2023
1Rare Diseases (Rare Disease)
03/2023
1Left Ventricular Dysfunction
01/2023
1Diabetes Mellitus
01/2023
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2023
1Overweight
01/2023
1Hyperlipidemias (Hyperlipidemia)
01/2023
1Hypertension (High Blood Pressure)
01/2023
1Disseminated Intravascular Coagulation
10/2022
1Vision Disorders (Hemeralopia)
10/2022
1Hemorrhage
10/2022
1Sepsis (Septicemia)
08/2022
1Febrile Neutropenia
08/2022
1Eosinophilia
01/2022
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2022
1Polycythemia Vera
01/2022
1Essential Thrombocythemia
01/2022
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022
1Carcinogenesis
01/2022
1Mycoses (Diseases, Fungus)
01/2021
1Chromosome Aberrations (Chromosome Abnormalities)
08/2017
1Aneuploidy (Aneuploid)
08/2017
1Genomic Instability
01/2017

Drug/Important Bio-Agent (IBA)

3Asparaginase (Elspar)FDA Link
01/2024 - 11/2022
3venetoclaxIBA
12/2023 - 01/2022
3nelarabine (506U78)FDA Link
11/2023 - 01/2016
2Azacitidine (5 Azacytidine)FDA Link
12/2023 - 01/2023
2tagraxofuspIBA
12/2023 - 03/2023
2Inotuzumab OzogamicinIBA
11/2023 - 01/2022
2Phosphotransferases (Kinase)IBA
11/2023 - 01/2018
2Etoposide (VP 16)FDA LinkGeneric
11/2023 - 01/2016
2ProdrugsIBA
11/2023 - 06/2023
2Tyrosine Kinase InhibitorsIBA
01/2023 - 04/2022
2RNA (Ribonucleic Acid)IBA
01/2022 - 12/2019
2Interferon Type IIBA
04/2008 - 12/2006
2CytokinesIBA
03/2007 - 12/2006
1Ciprofloxacin (Cipro)FDA LinkGeneric
03/2024
1Interleukin-3 (Interleukin 3)IBA
12/2023
1Diphtheria ToxinIBA
12/2023
1Interleukin-3 Receptors (Interleukin 3 Receptor)IBA
12/2023
1Proteins (Proteins, Gene)FDA Link
11/2023
1avapritinibIBA
11/2023
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
11/2023
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2023
1AntimetabolitesIBA
11/2023
1BilirubinIBA
08/2023
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2023
1Alanine Transaminase (SGPT)IBA
08/2023
1DeoxyguanosineIBA
06/2023
19-arabinofuranosylguanineIBA
06/2023
1isocitric acid (isocitrate)IBA
01/2023
1AnthracyclinesIBA
01/2023
1ivosidenibIBA
01/2023
1Complement System Proteins (Complement)IBA
11/2022
1Adrenal Cortex Hormones (Corticosteroids)IBA
11/2022
1Dacarbazine (DIC)FDA LinkGeneric
10/2022
1Retinaldehyde (Retinal)IBA
10/2022
1Anti-Bacterial Agents (Antibiotics)IBA
08/2022
1beta-LactamsIBA
08/2022
1Methicillin (Metin)FDA Link
08/2022
1GlucocorticoidsIBA
01/2022
1ChromatinIBA
01/2022
1Oncogene Proteins (Oncogene Protein)IBA
01/2022
1Imatinib Mesylate (Gleevec)FDA Link
01/2022
1Core Binding Factors (Core-Binding Factor)IBA
01/2022
1Polycomb Repressive Complex 2IBA
01/2022
1gilteritinibIBA
01/2021
1TriazolesIBA
01/2021
1Indicators and Reagents (Reagents)IBA
08/2019
1midostaurinIBA
12/2017
1Cell-Free Nucleic AcidsIBA
08/2017
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1CytosineIBA
01/2017
1Daunorubicin (Cerubidine)FDA LinkGeneric
03/2016

Therapy/Procedure

18Therapeutics
01/2024 - 12/2006
8Drug Therapy (Chemotherapy)
03/2024 - 09/2015
4Hematopoietic Stem Cell Transplantation
11/2016 - 07/2015
3Induction Chemotherapy
03/2024 - 10/2022
3Music Therapy
06/2023 - 04/2022
3Cell Transplantation
01/2021 - 01/2017
2Precision Medicine
01/2024 - 11/2022
2Aftercare (After-Treatment)
04/2022 - 01/2021
2Transplantation
01/2022 - 11/2016
2Stem Cell Transplantation
11/2016 - 02/2015